The 45th San Antonio Breast Cancer Symposium will host 10,000 clinicians and scientists from all over the world and is the largest and most prestigious scientific gathering on breast cancer research. This international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. VJOncology will be in attendance to help disseminate the latest learnings from the meeting.
View all videos

SABCS 2022

San Antonio Breast Cancer Symposium 2022
06–10 December 2022 | San Antonio, TX

📢And that’s a wrap on #ASCO23! We can go back home full of memories and an online journal full of content for you to catch up on! Visit http://vjoncology.com for our in-person coverage of #ASCO23 today!

@VJOncology @ASCO #ASCO23 #Cancer #OncTwitter #MedTwitter

🎥Today at #ASCO23, we spoke with @PTarantinoMD of @DanaFarber on the results of a population-based study assessing the prognosis and trends in chemo use for patients with stage IA TNBC.

➡️Full interview coming soon to http://VJOncology.com!

@ASCO #BreastCancer #BCSM #TNBC

🎥@RobinL_Jones of @royalmarsdenNHS discusses the INTRIGUE trial findings on ripretinib in patients with GIST at #ASCO2023. Although no PFS or OS improvements overall, patients pretreated with imatinib show OS improvement :

➡️⬅️

@ASCO #UroOnc #UroSoMe

Image for twitter card

Updated overall survival findings from the Phase III INTRIGUE trial

Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, discusses overall survival findings from the Ph...

ow.ly

🎥It was great speaking with Nikolaos Trikalinos, MD, of @WUSTLmed at #ASCO23 on the emerging treatment landscape for patients with advanced extrapulmonary neuroendocrine carcinoma!

Check out http://VJOncology.com for interviews with leading experts from the meeting!

@ASCO

🎥We had the pleasure of speaking to @JSabari of @nyulangone on KRAS-mutated non-small cell #lungcancer earlier this morning at #ASCO23 in Chicago!

📷Watch this space for the interview! http://VJOncology.com

@ASCO

#NSCLC #SCLC #LCSM https://twitter.com/i/web/status/1665753740085714944

Load More

SABCS 2022

San Antonio Breast Cancer Symposium 2022
06–10 December 2022 | San Antonio, TX
The 45th San Antonio Breast Cancer Symposium will host 10,000 clinicians and scientists from all over the world and is the largest and most prestigious scientific gathering on breast cancer research. This international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. VJOncology will be in attendance to help disseminate the latest learnings from the meeting.
View all videos

📢And that’s a wrap on #ASCO23! We can go back home full of memories and an online journal full of content for you to catch up on! Visit http://vjoncology.com for our in-person coverage of #ASCO23 today!

@VJOncology @ASCO #ASCO23 #Cancer #OncTwitter #MedTwitter

🎥Today at #ASCO23, we spoke with @PTarantinoMD of @DanaFarber on the results of a population-based study assessing the prognosis and trends in chemo use for patients with stage IA TNBC.

➡️Full interview coming soon to http://VJOncology.com!

@ASCO #BreastCancer #BCSM #TNBC

🎥@RobinL_Jones of @royalmarsdenNHS discusses the INTRIGUE trial findings on ripretinib in patients with GIST at #ASCO2023. Although no PFS or OS improvements overall, patients pretreated with imatinib show OS improvement :

➡️⬅️

@ASCO #UroOnc #UroSoMe

Image for twitter card

Updated overall survival findings from the Phase III INTRIGUE trial

Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, discusses overall survival findings from the Ph...

ow.ly

🎥It was great speaking with Nikolaos Trikalinos, MD, of @WUSTLmed at #ASCO23 on the emerging treatment landscape for patients with advanced extrapulmonary neuroendocrine carcinoma!

Check out http://VJOncology.com for interviews with leading experts from the meeting!

@ASCO

🎥We had the pleasure of speaking to @JSabari of @nyulangone on KRAS-mutated non-small cell #lungcancer earlier this morning at #ASCO23 in Chicago!

📷Watch this space for the interview! http://VJOncology.com

@ASCO

#NSCLC #SCLC #LCSM https://twitter.com/i/web/status/1665753740085714944

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter